Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017
- PMID: 29067905
- PMCID: PMC5710115
- DOI: 10.2807/1560-7917.ES.2017.22.42.17-00659
Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017
Abstract
We describe a multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and azithromycin intermediate resistance in a heterosexual man in Denmark, 2017. Whole genome sequencing of the strain GK124 identified MSLT ST1903, NG-MAST ST1614 and all relevant resistance determinants including similar penA resistance mutations previously described in ceftriaxone-resistant gonococcal strains. Although treatment with ceftriaxone 0.5 g plus azithromycin 2 g was successful, increased awareness of spread of gonococcal strains threatening the recommended dual therapy is crucial.
Keywords: Neisseria gonorrhoeae; Resfinder; STD; antibiotic; multidrug-resistant; treatment.
Conflict of interest statement
Similar articles
-
Multidrug-resistant Neisseria gonorrhoeae isolate, belonging to the internationally spreading Japanese FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, Ireland, August 2018.Euro Surveill. 2018 Nov;23(47):1800617. doi: 10.2807/1560-7917.ES.2018.23.47.1800617. Euro Surveill. 2018. PMID: 30482267 Free PMC article.
-
Multidrug-resistant Neisseria gonorrhoeae failing treatment with ceftriaxone and doxycycline in France, November 2017.Euro Surveill. 2018 May;23(21):1800264. doi: 10.2807/1560-7917.ES.2018.23.21.1800264. Euro Surveill. 2018. PMID: 29845928 Free PMC article.
-
Correlation between In vitro susceptibility and treatment outcome with azithromycin in gonorrhoea: a prospective study.Indian J Med Microbiol. 2007 Oct;25(4):354-7. doi: 10.4103/0255-0857.37338. Indian J Med Microbiol. 2007. PMID: 18087084 Clinical Trial.
-
Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century.Med Microbiol Immunol. 2020 Apr;209(2):95-108. doi: 10.1007/s00430-019-00651-4. Epub 2019 Dec 4. Med Microbiol Immunol. 2020. PMID: 31802195 Free PMC article. Review.
-
Background review for the '2020 European guideline for the diagnosis and treatment of gonorrhoea in adults'.Int J STD AIDS. 2021 Feb;32(2):108-126. doi: 10.1177/0956462420948739. Epub 2020 Dec 15. Int J STD AIDS. 2021. PMID: 33323071 Review.
Cited by
-
Emergence and evolution of mosaic penA-60 and penA-237 alleles in a Neisseria gonorrhoeae core genogroup that was historically susceptible to extended spectrum cephalosporins.Front Microbiol. 2024 Oct 1;15:1401303. doi: 10.3389/fmicb.2024.1401303. eCollection 2024. Front Microbiol. 2024. PMID: 39411431 Free PMC article.
-
In silico gepotidacin target mining among 33 213 global Neisseria gonorrhoeae genomes from 1928 to 2023 combined with gepotidacin MIC testing of 22 gonococcal isolates with different GyrA and ParC substitutions.J Antimicrob Chemother. 2024 Sep 3;79(9):2221-2226. doi: 10.1093/jac/dkae217. J Antimicrob Chemother. 2024. PMID: 39004438 Free PMC article.
-
Antimicrobial susceptibilities of Neisseria gonorrhoeae in Canada, 2021.Can Commun Dis Rep. 2023 Sep 1;49(9):388-397. doi: 10.14745/ccdr.v49i09a05. eCollection 2023 Sep 1. Can Commun Dis Rep. 2023. PMID: 38463902 Free PMC article.
-
Managing treatment failure in Neisseria gonorrhoeae infection: current guidelines and future directions.Lancet Infect Dis. 2024 Aug;24(8):e532-e538. doi: 10.1016/S1473-3099(24)00001-X. Epub 2024 Feb 14. Lancet Infect Dis. 2024. PMID: 38367636 Free PMC article. Review.
-
Analytical and clinical validation of a multiplex PCR assay for detection of Neisseria gonorrhoeae and Chlamydia trachomatis including simultaneous LGV serotyping on an automated high-throughput PCR system.Microbiol Spectr. 2024 Mar 5;12(3):e0275623. doi: 10.1128/spectrum.02756-23. Epub 2024 Feb 12. Microbiol Spectr. 2024. PMID: 38345391 Free PMC article.
References
-
- Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother. 2012;56(3):1273-80. 10.1128/AAC.05760-11 - DOI - PMC - PubMed
-
- Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother. 2011;55(7):3538-45. 10.1128/AAC.00325-11 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials

